Apollo Hospitals Enterprise Ltd

Apollo Hospitals Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Apollo Hospitals Enterprise Ltd

₹ 7,242 -0.91%
30 Jun - close price
apollohospitals.com BSE: 508869 NSE: APOLLOHOSP
About

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.

Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies,
Primary Care & Diagnostic Clinics and several Retail Health models. [1]

Key Points

Business Segments
1) Healthcare Services (52% in H1 FY25 vs 55% in FY22): [1] [2] The company has a capacity of 10,134 beds in 73 hospitals located in India and overseas, out of which 8,709 beds are located in 45 owned hospitals, 639 beds in Day Surgery & Cradles and 790 beds are in 6 hospitals under management through operations and management contracts. [3]

Website BSE NSE
  • Market Cap ₹ 1,04,165 Cr.
  • Current Price ₹ 7,242
  • High / Low ₹ 7,545 / 6,001
  • Stock P/E 80.4
  • Book Value ₹ 607
  • Dividend Yield 0.22 %
  • ROCE 17.1 %
  • ROE 15.8 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has delivered good profit growth of 29.3% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 24.6%

Cons

  • Stock is trading at 11.9 times its book value
  • The company has delivered a poor sales growth of -3.49% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of Nifty 50 BSE 500 BSE Healthcare BSE 100 BSE 200

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
1,421 1,530 1,716 1,639 1,641 1,688 1,866 1,824 1,895 1,937 2,135 2,055 2,075
1,089 1,141 1,263 1,222 1,218 1,271 1,387 1,374 1,444 1,466 1,595 1,543 1,554
Operating Profit 332 388 453 417 423 418 479 450 450 471 540 512 521
OPM % 23% 25% 26% 25% 26% 25% 26% 25% 24% 24% 25% 25% 25%
24 10 43 55 43 18 65 52 46 27 121 108 92
Interest 58 60 58 60 61 61 60 61 69 64 65 62 63
Depreciation 105 89 92 89 97 93 93 97 115 103 108 108 130
Profit before tax 193 250 346 323 309 282 391 344 312 332 488 449 420
Tax % 21% -33% 19% 24% 26% 24% 25% 24% 24% 24% 24% 24% 21%
154 333 279 246 227 214 295 263 239 252 370 342 333
EPS in Rs 10.69 23.17 19.41 17.08 15.78 14.89 20.50 18.28 16.61 17.51 25.71 23.76 23.19
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
3,835 4,543 5,523 6,301 7,183 8,337 9,794 4,654 6,098 6,525 7,274 8,202
3,218 3,862 4,776 5,527 6,348 7,314 8,377 3,938 4,677 4,831 5,476 6,158
Operating Profit 617 681 748 774 835 1,022 1,418 715 1,421 1,694 1,798 2,044
OPM % 16% 15% 14% 12% 12% 12% 14% 15% 23% 26% 25% 25%
20 28 4 26 7 8 173 137 131 139 180 348
Interest 87 83 134 200 240 268 426 340 244 239 250 254
Depreciation 129 158 200 241 272 300 482 421 363 367 399 449
Profit before tax 420 467 417 359 330 462 682 91 945 1,228 1,329 1,688
Tax % 21% 26% 20% 21% 29% 35% 31% -15% 30% 12% 24% 23%
331 347 334 285 233 303 470 105 665 1,085 1,010 1,296
EPS in Rs 23.77 24.91 24.00 20.50 16.76 21.76 33.80 7.30 46.26 75.45 70.28 90.16
Dividend Payout % 24% 23% 25% 29% 30% 28% 18% 41% 25% 20% 23% 31%
Compounded Sales Growth
10 Years: 6%
5 Years: -3%
3 Years: 10%
TTM: 13%
Compounded Profit Growth
10 Years: 14%
5 Years: 29%
3 Years: 26%
TTM: 32%
Stock Price CAGR
10 Years: 19%
5 Years: 41%
3 Years: 25%
1 Year: 17%
Return on Equity
10 Years: 11%
5 Years: 13%
3 Years: 15%
Last Year: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 70 70 70 70 70 70 70 72 72 72 72 72
Reserves 2,895 3,092 3,246 3,509 3,624 3,814 3,919 5,130 6,039 6,853 7,639 8,662
1,079 1,681 2,346 2,757 2,991 3,238 3,160 3,050 2,752 2,520 3,222 3,090
812 978 1,176 857 1,127 1,307 2,996 1,478 1,545 1,335 1,472 1,548
Total Liabilities 4,857 5,820 6,838 7,193 7,812 8,428 10,144 9,729 10,408 10,780 12,405 13,372
1,989 2,428 3,061 3,600 3,762 3,970 6,056 5,038 5,121 5,078 6,032 6,361
CWIP 481 512 536 328 698 819 227 219 24 96 200 294
Investments 690 713 877 1,064 900 1,085 1,076 2,091 2,059 2,217 2,621 3,911
1,697 2,167 2,364 2,202 2,452 2,554 2,786 2,381 3,204 3,389 3,553 2,807
Total Assets 4,857 5,820 6,838 7,193 7,812 8,428 10,144 9,729 10,408 10,780 12,405 13,372

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
303 389 626 632 539 907 1,096 916 1,201 1,224 1,191 1,742
-310 -681 -910 -804 -378 -776 -264 -781 -504 -588 -835 -1,046
-40 332 290 130 -106 -160 -771 -176 -577 -779 -297 -739
Net Cash Flow -47 40 7 -42 54 -28 62 -41 120 -143 59 -43

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 45 44 36 38 38 40 36 94 49 46 41 36
Inventory Days 48 50 49 48 52 47 50 63 28 19 22 21
Days Payable 45 48 51 43 45 45 51 254 124 124 138 134
Cash Conversion Cycle 48 46 34 44 44 42 35 -96 -46 -59 -76 -77
Working Capital Days 44 48 35 40 36 23 17 39 83 89 78 78
ROCE % 13% 12% 11% 9% 9% 11% 13% 6% 13% 16% 15% 17%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.34%
48.48% 49.09% 47.94% 46.96% 47.93% 46.15% 46.25% 45.63% 43.92% 45.37% 45.27% 42.74%
15.64% 15.28% 16.56% 17.76% 17.02% 18.59% 18.87% 19.55% 21.13% 19.94% 19.97% 22.29%
0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23%
6.32% 6.07% 5.94% 5.72% 5.49% 5.68% 5.32% 5.26% 5.38% 5.12% 5.21% 5.41%
No. of Shareholders 1,46,3201,35,9231,31,6361,31,9371,20,0301,31,5651,19,5781,30,6641,27,7541,19,2451,27,8021,34,058

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls